Analgesic, Anesthetic and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) (U01)

This award is intended to provide support for developing and maintaining an organizational infrastructure to support a broad-based public-private partnership under FDA's Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) Initiative.

Specific

credit:


projects under the ACTTION Initiative may also be funded.
Related Programs

Food and Drug Administration_Research

Department of Health and Human Services


Agency: Food and Drug Administration

Office:

Estimated Funding: $800,000


Relevant Nonprofit Program Categories





Obtain Full Opportunity Text:
Full Announcement of RFA-FD-16-047

Additional Information of Eligibility:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.

Foreign components, as defined in the HHS Grants Policy Statement, are not allowed.

Full Opportunity Web Address:


Contact:


Agency Email Description:


Agency Email:
eric.bozoian@fda.hhs.gov

Date Posted:
2016-04-19

Application Due Date:
2016-06-20

Archive Date:
2016-07-20


First Enterprise Business Agency (FEBA), a Nottingham-based business support organization, is a contender for two categories at the first Citi Microentrepreneurship Awards to be held this coming February.






More Federal Domestic Assistance Programs


Refugee and Entrant Assistance_Discretionary Grants | Federal Reimbursement of Emergency Health Services Furnished to Undocumented Aliens | Technology Innovation Program (TIP) | Laura Bush 21st Century Librarian Program | Nonprofit Capacity Building |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders